ORIGINAL ARTICLES
Prevalence of asthma and other allergic diseases in an adolescent population: association with gender and race

https://doi.org/10.1016/S1081-1206(10)62688-9Get rights and content

Objectives

To estimate the prevalence and severity of asthma in an adolescent population by sex and race.

Methods

Cross-sectional, population-based survey of school children.

Setting

Midwestern city experiencing damage from the 1993 Mississippi River flood. Participants: 2,693 children attending grades 7 to 12.

Measurements

Questions from the International Study of Asthma and Allergies in Childhood (ISAAC).

Results

Two thousand six hundred ninety-three children were surveyed, for a response rate of 90%. In this population, 16.4% reported having ever been diagnosed with asthma; 25% reported wheezing in the last 12 months; 32% reported symptoms of rhinitis in the last 12 months; and 22% reported ever having hay fever. The prevalence rate for current asthma was 12.6%. Female students had significantly greater prevalence rates for current asthma (16.4% vs 9.0%, OR = 1.85); ever-diagnosed asthma (18.5% vs 14.3%, OR = 1.36); wheezing ≥ 4 times in the last 12 months (12.0% vs 5.6%, OR = 1.95); current rhinitis (38.7% vs 25.4%, OR = 1.73); and hay fever (26.4% vs 18.4%, OR = 1.57). All associations with sex remained significant, except ever-diagnosed asthma, after controlling for other known risk factors in logistic regression. African-Americans had higher prevalence rates than other races with differences reaching statistical significance for ever-diagnosed asthma and current asthma; however, these relationships did not remain significant after controlling for other known risk factors in logistic regression.

Conclusions

Our prevalence rates were similar to those reported by other studies that used the ISAAC questionnaire. Female students reported significantly more asthma, wheezing, rhinitis, and hay fever than male students. Female students also reported more severe symptoms and a greater number of emergency room and hospital admissions.

REFERENCES (48)

  • R Evans et al.

    National trends in the morbidity and mortality of asthma in the US: prevalence, hospitalization and death from asthma over two decades: 1965–1984

    Chest

    (1987)
  • KB Weiss et al.

    Changing patterns of asthma mortality: identifying target populations at high risk

    JAMA

    (1990)
  • RM Sly

    Mortality from asthma in children 1979–1984

    Ann Allergy

    (1988)
  • HM Arrighi

    US asthma mortality: 1941 to 1989

    Ann Allergy Asthma Immunol

    (1995)
  • Y Mao et al.

    Increased rates of illness and death from asthma in Canada

    Can Med Assoc J

    (1987)
  • R Jackson et al.

    International trends in asthma mortality: 1970 to 1985

    Chest

    (1988)
  • KB Weiss et al.

    Breathing better or wheezing worse? The changing epidemiology of asthma morbidity and mortality

    Annu Rev Public Health

    (1993)
  • PJ Gergen et al.

    National survey of prevalence of asthma among children in the United States. 1976 to 1980

    Pediatrics

    (1988)
  • A Bauman

    Has the prevalence of asthma symptoms increased in Australian children?

    J Paediatr Child Health

    (1993)
  • CF Robertson et al.

    Prevalence of asthma in Melbourne school children: changes over 26 years

    Br Med J

    (1991)
  • J Manfreda et al.

    Trends in physician-diagnosed asthma prevalence in Manitoba between 1980 and 1990

    Chest

    (1993)
  • PGJ Burney et al.

    Has the prevalence of asthma increased in children? Evidence from the national survey of health and growth 1973–86

    Br Med J

    (1990)
  • ML Burr et al.

    Changes in asthma prevalence: two surveys 15 years apart

    Arch Dis Child

    (1989)
  • EA Mitchell et al.

    Prevalence, severity and medical management of asthma in European school children in 1985 and 1991

    J Paediatr Child Health

    (1994)
  • M Weitzman et al.

    Recent trends in the prevalence and severity of childhood asthma

    JAMA

    (1992)
  • MI Asher et al.

    International study of asthma and allergies in childhood (ISAAC): rationale and methods

    Eur Respir J

    (1995)
  • N Pearce et al.

    Self-reported prevalence of asthma symptoms in children in Australia, England, Germany and New Zealand: an international comparison using the ISAAC protocol

    Eur Respir J

    (1993)
  • B Robson et al.

    Prevalence of asthma symptoms among adolescents in the Wellington region, by area and ethnicity

    NZ Med J

    (1993)
  • ISAAC Co-ordinating Committee

    Manual for the International Study of Asthma and Allergies in Childhood (ISAAC)

    (1992)
  • B Kaur et al.

    Prevalence of asthma symptoms, diagnosis, and treatment in 12–14 year old children across Great Britain (International Study of Asthma and Allergies in Childhood, ISAAC UK)

    Br Med J

    (1998)
  • DYT Goh et al.

    Prevalence and severity of asthma, rhinitis, and eczema in Singapore schoolchildren

    Arch Dis Child

    (1996)
  • PJ Manning et al.

    Asthma, hay fever and eczema in Irish teenagers (ISAAC protocol)

    Ir Med J

    (1997)
  • J Pekkanen et al.

    Prevalence of asthma symptoms in video and written questionnaires among children in four regions of Finland

    Eur Respir J

    (1997)
  • RM Busquets et al.

    Prevalence of asthma-related symptoms and bronchial responsiveness to exercise in children aged 13–14 yrs in Barcelona, Spain

    Eur Respir J

    (1996)
  • Cited by (107)

    • Risk of developing major depression and bipolar disorder among adolescents with atopic diseases: A nationwide longitudinal study in Taiwan

      2016, Journal of Affective Disorders
      Citation Excerpt :

      Atopic diseases include atopic dermatitis, allergic rhinitis, allergic conjunctivitis, and asthma, and have been regarded as the most common chronic disorders of childhood and adolescence (Fagan et al., 2001; Stone 2003; Ait-Khaled et al., 2009; Amarasekera et al., 2010).

    View all citing articles on Scopus

    This study was supported by a grant from the Illinois Department of Public Health via the Center for Disease Control and Prevention.

    View full text